ArticleCell death & disease2024

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

Tao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.